Literature DB >> 24662375

Economic trends from 2003 to 2010 for perioperative myocardial infarction: a retrospective, cohort study.

Belinda L Udeh1, Jarrod E Dalton, J Steven Hata, Chiedozie I Udeh, Daniel I Sessler.   

Abstract

BACKGROUND: Perioperative myocardial infarction (PMI) is a major surgical complication that is costly and causes much morbidity and mortality. Diagnosis and treatment of PMIs have evolved over time. Many treatments are expensive but may reduce ancillary expenses including the duration of hospital stay. The time-dependent economic impact of novel treatments for PMI remains unexplored. The authors thus evaluated absolute and incremental costs of PMI over time and discharge patterns.
METHODS: Approximately 31 million inpatient discharges were analyzed between 2003 and 2010 from the California State Inpatient Database. PMI was defined using International Classification of Diseases, Ninth Revision, Clinical Modification codes. Propensity matching generated 21,637 pairs of comparable patients. Quantile regression modeled incremental charges as the response variable and year of discharge as the main predictor. Time trends of incremental charges adjusted to 2012 dollars, mortality, and discharge destination was evaluated.
RESULTS: Median incremental charges decreased annually by $1,940 (95% CI, $620 to $3,250); P < 0.001. Compared with non-PMI patients, the median length of stay of patients who experienced PMI decreased significantly over time: yearly decrease was 0.16 (0.10 to 0.23) days; P < 0.001. No mortality differences were seen; but over time, PMI patients were increasingly likely to be transferred to another facility.
CONCLUSIONS: Reduced incremental cost and unchanged mortality may reflect improving efficiency in the standard management of PMI. An increasing fraction of discharges to skilled nursing facilities seems likely a result from hospitals striving to reduce readmissions. It remains unclear whether this trend represents a transfer of cost and risk or improves patient care.

Entities:  

Mesh:

Year:  2014        PMID: 24662375      PMCID: PMC4062595          DOI: 10.1097/ALN.0000000000000233

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  16 in total

1.  Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves.

Authors:  James Ramsay; Stanton Shernan; Jane Fitch; Paul Finnegan; Thomas Todaro; Thomas Filloon; Nancy A Nussmeier
Journal:  J Thorac Cardiovasc Surg       Date:  2005-02       Impact factor: 5.209

Review 2.  Perioperative cardiac morbidity.

Authors:  D T Mangano
Journal:  Anesthesiology       Date:  1990-01       Impact factor: 7.892

3.  Impact of present-on-admission indicators on risk-adjusted hospital mortality measurement.

Authors:  Jarrod E Dalton; Laurent G Glance; Edward J Mascha; John Ehrlinger; Nassib Chamoun; Daniel I Sessler
Journal:  Anesthesiology       Date:  2013-06       Impact factor: 7.892

4.  Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery.

Authors:  Bernard L Croal; Graham S Hillis; Patrick H Gibson; Mohammed T Fazal; Hussein El-Shafei; George Gibson; Robert R Jeffrey; Keith G Buchan; Douglas West; Brian H Cuthbertson
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

5.  Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group.

Authors:  D T Mangano; W S Browner; M Hollenberg; J Li; I M Tateo
Journal:  JAMA       Date:  1992-07-08       Impact factor: 56.272

6.  Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.

Authors:  P J Devereaux; Homer Yang; Salim Yusuf; Gordon Guyatt; Kate Leslie; Juan Carlos Villar; Denis Xavier; Susan Chrolavicius; Launi Greenspan; Janice Pogue; Prem Pais; Lisheng Liu; Shouchun Xu; German Málaga; Alvaro Avezum; Matthew Chan; Victor M Montori; Mike Jacka; Peter Choi
Journal:  Lancet       Date:  2008-05-12       Impact factor: 79.321

7.  Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data.

Authors: 
Journal:  Circulation       Date:  1983-11       Impact factor: 29.690

8.  Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery.

Authors:  Giora Landesberg; Vadim Shatz; Inna Akopnik; Yehuda G Wolf; Michael Mayer; Yacov Berlatzky; Charles Weissman; Morris Mosseri
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

9.  Long-term prognosis after peri-operative cardiac complications.

Authors:  M Charlson; J Peterson; T P Szatrowski; R MacKenzie; J Gold
Journal:  J Clin Epidemiol       Date:  1994-12       Impact factor: 6.437

10.  Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization.

Authors:  John C Chen; Padma Kaul; Jerrold H Levy; Axel Haverich; Philippe Menasché; Peter K Smith; Michel Carrier; Edward D Verrier; Frans Van de Werf; Russel Burge; Paul Finnegan; Daniel B Mark; Stanton K Shernan
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

View more
  2 in total

1.  Morbidity and Mortality After Acute Myocardial Infarction After Elective Major Noncardiac Surgery.

Authors:  Sylvia L Ranjeva; Avery Tung; Peter Nagele; Daniel S Rubin
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-10-15       Impact factor: 2.628

2.  Analysis of hospitalization expenditures and influencing factors for inpatients with coronary heart disease in a tier-3 hospital in Xi'an, China: A retrospective study.

Authors:  Jing-Mei Ding; Xian-Zhi Zhang; Xue-Jun Hu; Huo-Liang Chen; Min Yu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.